Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

$20 Million Grant: Cenegenics Congratulates Dr. Robert D. Langer, a Noted Principal Investigator and Board Member of Cenegenics Education and Research Foundation
  • USA - English


News provided by

Cenegenics

Sep 27, 2013, 06:00 ET

Share this article

Share toX

Share this article

Share toX

Dr. Robert D. Langer: Noted principal investigator for UNLV's "game-changing" $20 million grant & board member of Cenegenics Education and Research Foundation
Dr. Robert D. Langer: Noted principal investigator for UNLV's "game-changing" $20 million grant & board member of Cenegenics Education and Research Foundation

I fully expect that the research we will do will be eye-opening for people in other parts of the country—exploring different avenues that will have meaningful impact on health well beyond our region.

Post this

Las Vegas, NV (PRWEB) September 27, 2013 -- Dr. Robert D. Langer—noted international research leader in studies focused on healthy aging and a member of the Board of Trustees for Cenegenics Education and Research Foundation (CERF)—is principal investigator for a $20 million grant awarded by the National Institutes of Health (NIH) to UNLV for clinical research across seven Mountain West states to solve regional health problems, announced Cenegenics Education and Research Foundation (CERF). CERF focuses on investigative research and physician education in preventive medicine as well as oversees Cenegenics’ certifying body, research committee and medical advisory committee.

According to Langer, this grant is a true game-changer for the Mountain West states, recognizing this part of the country as having much to contribute to our understanding of health. Historically, these seven states have done most of their research in basic science without much opportunity to do clinical or translational research—bench-to-bedside work that takes promising concepts from a laboratory perspective and makes them relevant to people with practical, clinical applications, such as age management medicine or novel approaches to clinical questions. The hefty grant also allows the region to focus on issues unique to this part of the world, providing a fresh look at health as seen from an environment different than the metropolitan places where most academic centers are located.

“One of the interesting things about science is that the more you think out of the box, the better. Human nature is to go for things in a straight line, that’s most comfortable. The reality is that good science often comes from zig-zags. Quite often the research coming out of major academic medical centers is based on the current model of thinking regarding health. The Mountain West will contribute fresh perspectives. I fully expect that the research we will do will be eye-opening for people in other parts of the country—exploring different avenues that will have meaningful impact on health well beyond our region,” Langer said.

The structure of the grant includes core resources for education and mentoring, biostatistical support and editorial support, the basic tools to help younger investigators who need some gaps in knowledge and experience filled in to be competitive at the NIH level. It also will provide resources to help researchers who have been successful in bench science move into human research.

About half of the grant money is targeted for pilot grants and support for faculty at the 13 participating institutions to develop collaborations: UNLV, UNR (via the University of Nevada School of Medicine), University of Alaska (Anchorage), University of Alaska (Fairbanks), University of Hawaii (Manoa), Boise State University, Idaho State University, University of Idaho, Montana State University, University of Montana, University of New Mexico, New Mexico State University and the University of Wyoming.

“We are thrilled for Dr. Langer and for UNLV’s receiving such a prestigious grant. This further underscores Dr. Langer’s career-long commitment to research centered on a health-wellness and preventive medicine model. Clearly, this type of research work also dovetails into CERF’s mission of investigative research and physician education in preventive medicine,” Dr. Beth Traylor said. Traylor is CERF’s president as well as a Cenegenics physician partner and senior Institute physician.

Physicians interested in learning more about training and certification in age management medicine should visit the Age Management Medicine Education Foundation site.

Follow Cenegenics on Facebook, Twitter and get health tips, patient celebrity blogs and health news on their portal site, CenegenicsPost.

To schedule an interview with Cenegenics Education and Research Foundation, please contact Ann Castro, Cenegenics Director of Media Relations: 702.953.1588.

About Robert D. Langer, MD, MPH
Dr. Robert D. Langer is the founder, principal scientist and medical director of the Jackson Hole Center for Preventive Medicine. He is associate dean for clinical and transitional research and professor of family medicine at the University of Nevada School of Medicine and professor of allied health sciences at the University of Nevada-Las Vegas. Dr. Langer is Diplomate of the American Board of Preventive Medicine and a Fellow of the American College of Preventive Medicine, the American Academy of Family Physicians and the American Heart Association Scientific Councils. He has served as the principal investigator for more than 30 national and international clinical trials and observational studies with cumulative funding of more than $46 million over the past 25 years. He is the author of over 180 publications in peer-reviewed literature and a sought-after speaker, presenting invited lectures in 13 countries on 4 continents. He earned his medical degree from the Abraham Lincoln School of Medicine - University of Illinois, completed an internship in family medicine at Overlook Hospital (Summit, New Jersey) and a residency in preventive medicine at the University of California - San Diego State University, where he also earned an MPH in epidemiology.

About Cenegenics Education and Research Foundation
The nonprofit Cenegenics Education and Research Foundation focuses on investigative research and physician education in preventive medicine as well as oversees Cenegenics’ certifying body, the Age Management Medicine Education Foundation (AMMEF), the Cenegenics Research Foundation (CERF) and a physician-led Medical Advisory Committee (MAC). CERF’s various collaborative investigative research with noted professors from UCLA’s David Geffen School of Medicine and the University of Miami - Miller School of Medicine have been published in peer-reviewed journals.

Ann Castro, Director of Public Relations, Cenegenics, http://www.cenegenics.com, +1 (702) 953-1588, [email protected]

Modal title

Cenegenics Education and Research Foundation: Nonprofit focused on investigative research and physician education in preventive medicine
Cenegenics Education and Research Foundation: Nonprofit focused on investigative research and physician education in preventive medicine
Cenegenics Education and Research Foundation: Nonprofit focused on investigative research and physician education in preventive medicine

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.